Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection

Author： Cuestas María   Mathet Verónica   Oubiña José   Sosnik Alejandro  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.27, Iss.7, 2010-07, pp. : 1184-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine is effective in paediatric patients with chronic hepatitis B virus (HBV) infection

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Drug Targets in Hepatitis B Virus Infection

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 2, 2009-04 ,pp. : 105-116

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Current pharmacotherapy for hepatitis B infection

By Galan Mark V   Gordon Stuart C   Boyce Douglas  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1289-1298

Informa Healthcare

Access to resources Recommend Favorite

siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection

By Chen Yong   Mahato Ram  

Journal of Drug Targeting, Vol. 16, Iss. 2, 2008-02 ,pp. : 140-148

Informa Healthcare

Access to resources Recommend Favorite